FN1 knockout inhibits tumorigenesis but promotes lung metastasis in hepatocellular carcinoma
Xia & He Publishing Inc.Primary liver cancer is the sixth most common malignancy and third leading cause of cancer‑related deaths. HCC accounts for ~90% of cases, with HBV infection as a major aetiological factor. Poor prognosis is largely due to late diagnosis and high metastatic propensity.
Fibronectin (FN1), an ECM glycoprotein, is generally oncogenic by remodelling the ECM and activating integrin‑driven pathways. However, FN1 deficiency can paradoxically impair collagen barriers and promote metastasis. This duality is context‑dependent. HBV DNA integration into FN1 occurs preferentially in adjacent non‑cancerous tissues, contradicting FN1's pro‑oncogenic function. Clarifying FN1's role in HCC is therefore important.
Primary liver cancer is the sixth most common malignancy and third leading cause of cancer‑related deaths. HCC accounts for ~90% of cases, with HBV infection as a major aetiological factor. Poor prognosis is largely due to late diagnosis and high metastatic propensity.
Fibronectin (FN1), an ECM glycoprotein, is generally oncogenic by remodelling the ECM and activating integrin‑driven pathways. However, FN1 deficiency can paradoxically impair collagen barriers and promote metastasis. This duality is context‑dependent. HBV DNA integration into FN1 occurs preferentially in adjacent non‑cancerous tissues, contradicting FN1's pro‑oncogenic function. Clarifying FN1's role in HCC is therefore important.
- Journal
- Journal of Clinical and Translational Hepatology